Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury

Cysteinyl leukotrienes (CysLTs) have been implicated as inflammatory mediators of cardiovascular disease. Three distinct CysLT receptor subtypes transduce the actions of CysLTs but the role of the endothelial CysLT, receptor (CysLT(2)R) in cardiac function is unknown. Here, we investigated the role of CysLT(2)R in myocardial ischemia-reperfusion (I/R) injury using transgenic (tg) mice overexpressing human CysLT(2)R in vascular endothelium and nontransgenic (ntg) littermates. Infarction size in tg mice increased 114% compared with ntg mice 48 hours after I/R, this increase was blocked by the CysLT receptor antagonist BAY-u9773. injection of I-125-albumin into the systemic circulation revealed significantly enhanced extravasation of the label in tg mice, indicating increased leakage of the coronary endothelium, combined with increased incidence of hemorrhage and cardiomyocyte apoptosis. Expression of proinflammatory genes such as Egr-1, VCAM-1, and ICAM was significantly increased in tg mice relative to ntg controls. Echocardiographic assessment 2 weeks after /R revealed decreased anterior wall thickness in tg mice. Further More, the postreperfusion time Constant tau of isovolumic relaxation was significantly increased in tg animals, indicating diastolic dysfunction. These results reveal that endothelium-targeted overexpression of CysLT(2)R aggravates myocardial I/R injury by increasing endothelial permeability and exacerbating inflammatory gene expression, leading to accelerated left ventricular remodeling, induction of peri-infarct zone cellular apoptosis, and impaired cardiac performance.